A detailed history of Deprince Race & Zollo Inc transactions in Baxter International Inc stock. As of the latest transaction made, Deprince Race & Zollo Inc holds 855,094 shares of BAX stock, worth $24.9 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares
855,094
Previous 866,301 1.29%
Holding current value
$24.9 Million
Previous $29 Million 12.04%
% of portfolio
0.63%
Previous 0.65%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$32.85 - $40.26 $368,149 - $451,193
-11,207 Reduced 1.29%
855,094 $32.5 Million
Q2 2024

Aug 14, 2024

SELL
$32.87 - $43.55 $357,691 - $473,911
-10,882 Reduced 1.24%
866,301 $29 Million
Q1 2024

May 15, 2024

SELL
$37.88 - $43.77 $344,783 - $398,394
-9,102 Reduced 1.03%
877,183 $37.5 Million
Q4 2023

Feb 14, 2024

BUY
$31.71 - $38.95 $5.84 Million - $7.17 Million
184,051 Added 26.21%
886,285 $34.3 Million
Q3 2023

Nov 14, 2023

SELL
$37.32 - $49.29 $974,238 - $1.29 Million
-26,105 Reduced 3.58%
702,234 $26.5 Million
Q2 2023

Aug 14, 2023

SELL
$39.98 - $47.68 $630,564 - $752,008
-15,772 Reduced 2.12%
728,339 $33.2 Million
Q1 2023

May 15, 2023

BUY
$37.58 - $52.57 $3.45 Million - $4.83 Million
91,902 Added 14.09%
744,111 $30.2 Million
Q4 2022

Feb 14, 2023

SELL
$49.7 - $57.71 $203,173 - $235,918
-4,088 Reduced 0.62%
652,209 $33.2 Million
Q3 2022

Nov 14, 2022

BUY
$53.86 - $66.8 $4.36 Million - $5.41 Million
81,005 Added 14.08%
656,297 $35.3 Million
Q2 2022

Aug 15, 2022

BUY
$63.83 - $80.0 $16.2 Million - $20.3 Million
254,246 Added 79.19%
575,292 $37 Million
Q1 2022

May 16, 2022

BUY
$76.85 - $89.45 $24.7 Million - $28.7 Million
321,046 New
321,046 $24.9 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $14.7B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Deprince Race & Zollo Inc Portfolio

Follow Deprince Race & Zollo Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deprince Race & Zollo Inc, based on Form 13F filings with the SEC.

News

Stay updated on Deprince Race & Zollo Inc with notifications on news.